Ganciclovir
NDC Package 51754-2500-3
Package Information
Ganciclovir is iNJECTION is contraindicated in patients who have experienced a clinically significant hypersensitivity reaction (e.g., anaphylaxis) to ganciclovir, valganciclovir or acyclovir. Marketed by Exela Pharma Sciences, Llc, this product is identified by NDC 51754-2500 and is authorized under FDA application NDA209347.
Identification & Billing
- RxCUI: 1872065 - ganciclovir 500 MG in 250 mL Injection
- RxCUI: 1872065 - 250 ML ganciclovir 2 MG/ML Injection
- RxCUI: 1872065 - ganciclovir 500 MG per 250 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51754 - Exela Pharma Sciences, Llc
- 51754-2500 - Ganciclovir
- 51754-2500-3 - 10 BAG in 1 POUCH / 250 mL in 1 BAG
- 51754-2500 - Ganciclovir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51754-2500). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51754-2500-3 identifies a specific commercial package of 10 bag in 1 pouch / 250 ml in 1 bag of Ganciclovir, labeled by Exela Pharma Sciences, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Exela Pharma Sciences, Llc on February 28, 2017. The current certification is valid through December 31, 2025.
How is this Exela Pharma Sciences, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51754250003. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
